Exploring GLP-1 prescribing and access trends using real-time EHR data
Time: 10:45 am
day: Conference Day Two
Details:
- Monitoring GLP-1 prescribing patterns and patient characteristics over time, by medication, and by FDA-labeled use
- Exploring whether pre-treatment A1c and BMI – measures of clinical need – have fallen over time for patients newly prescribed a GLP-1
- Assessing anti-obesity GLP-1 prescribing and dispensing trends among older adults to identify potential access barriers
